GEA
FLGT icon

Glen Eagle Advisors’s Fulgent Genetics FLGT Stock Holding History

Glen Eagle Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-132
Closed -$11.9K – 989
2021
Q3 		$11.9K Buy
132
+27
+26% +$2.45K ﹤0.01% 671
2021
Q2 		$9.68K Hold
105
– – ﹤0.01% 701
2021
Q1 		$10.1K Sell
105
-195
-65% -$20.1K ﹤0.01% 667
2020
Q4 		$15.6K Hold
300
– – 0.01% 542
2020
Q3 		$12K Hold
300
– – 0.01% 557
2020
Q2 		$4.8K Hold
300
– – ﹤0.01% 676
2020
Q1 		$3.23K Hold
300
– – ﹤0.01% 676
2019
Q4 		$3.87K Buy
300
+200
+200% +$2.38K ﹤0.01% 734
2019
Q3 		$1.04K Buy
+100
New +$948 ﹤0.01% 749

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Glen Eagle Advisors's FLGT Position: Q4 2021 in Review

Glen Eagle Advisors sold out of Fulgent Genetics (FLGT) in Q4 2021, closing a stake of 132 shares — an estimated $11.9K sold.

Glen Eagle Advisors first reported a position in FLGT in Q3 2019 and held it in 9 quarters. The position peaked at $15.6K in Q4 2020. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

  • Glen Eagle Advisors reported no remaining Fulgent Genetics position as of Q4 2021 after selling out during the quarter.
  • Glen Eagle Advisors sold 132 Fulgent Genetics shares in Q4 2021, an estimated $11.9K.
  • Glen Eagle Advisors first reported a position in Fulgent Genetics in Q3 2019 and held it in 9 quarters.
  • Glen Eagle Advisors's Fulgent Genetics position peaked at $15.6K in Q4 2020.
  • 299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on Glen Eagle Advisors's 13F filing for Q4 2021, filed 13 Aug 2024.